Status:
COMPLETED
Tranexamic Acid and Depot-Medroxyprogesterone Acetate for Perimenopausal Irregular Uterine Bleeding
Lead Sponsor:
Assiut University
Conditions:
Uterine Bleeding
Eligibility:
FEMALE
40-55 years
Phase:
NA
Brief Summary
Abnormal uterine bleeding is a symptom and not a disease. It is one of the most frequently encountered complaints in gynecologic practice. It accounts for more than 70% of all gynecological consultati...
Eligibility Criteria
Inclusion
- Patients diagnosed, clinically as peri-menopausal abnormal uterine bleeding with normal pelvic examination.
- Patient's age ranging from 40- 55y.
Exclusion
- Post menopausal women
- Presence of fibroids, adenomyosis, polyp, adnexal mass, endometrial hyperplasia with atypia, and breast malignancy).
- Patients with uncontrolled hypertension.
- Patient of abnormal bleeding profile.
- history of liver impairment and renal insufficiency
- Patients seeking for surgical management.
Key Trial Info
Start Date :
February 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 1 2022
Estimated Enrollment :
110 Patients enrolled
Trial Details
Trial ID
NCT04710017
Start Date
February 1 2021
End Date
May 1 2022
Last Update
April 24 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Women Health Hospital - Assiut university
Asyut, Egypt, 71111